• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[从原生动物中分离出的脂质制剂对金黄仓鼠实验性利什曼病的影响]

[Effect of lipid preparations isolated from protozoa on experimental leishmaniasis in golden hamsters].

作者信息

Saf'ianova V M, Emel'ianova L P, Sukhareva N N, Uriniuk V M

出版信息

Antibiotiki. 1978 Nov;23(11):1918-24.

PMID:363050
Abstract

The effect of lipid preparations Nos. 59 and 60 isolated from Protozoa on experimental leishmaniosis of golden hamsters was studied. Preparations Nos. 59 and 60 are water-soluble derivatives of fatty acids isolated from Trypanosoma lewisi and Astasia longa respectively. It was found that both preparations administered to the animals simultaneously with the causative agent or after formation of the leishmaniosis infiltrates inhibited the development of the disease clinical signs. Such an effect of the preparations was observed only during the period of the animals exposure to them. After discontinuation of the treatment the development of the clinical process proceeded the same as in the control animals. The lipid preparation No. 60 differing from preparation No. 59 by high content of C20-poly-unsaturated fatty acids was more active and induced a significant decrease in the size of the leishmaniosis infiltrates formed. Preparation No. 60 was more effective in the treatment of the animals infected with L. tropica major than in the animals infected with L. tropica minor. Preparation No. 59 had no significant effect on multiplication and morphology of the parazites.

摘要

研究了从原生动物中分离出的59号和60号脂质制剂对金黄仓鼠实验性利什曼病的影响。59号和60号制剂分别是从路氏锥虫和长眼虫中分离出的脂肪酸的水溶性衍生物。结果发现,这两种制剂在与病原体同时给药或在利什曼病浸润形成后给药时,均能抑制疾病临床症状的发展。制剂的这种作用仅在动物接触它们的期间观察到。停止治疗后,临床病程的发展与对照动物相同。60号脂质制剂与59号制剂不同,其C20多不饱和脂肪酸含量高,活性更强,能使形成的利什曼病浸润灶大小显著减小。60号制剂对感染大型热带利什曼原虫的动物的治疗效果比对感染小型热带利什曼原虫的动物更有效。59号制剂对寄生虫的增殖和形态没有显著影响。

相似文献

1
[Effect of lipid preparations isolated from protozoa on experimental leishmaniasis in golden hamsters].[从原生动物中分离出的脂质制剂对金黄仓鼠实验性利什曼病的影响]
Antibiotiki. 1978 Nov;23(11):1918-24.
2
[Antitumor activity of fatty acid derivatives isolated from protozoa].[从原生动物中分离出的脂肪酸衍生物的抗肿瘤活性]
Antibiotiki. 1977 Aug;22(8):727-34.
3
[New biologically active substances from protozoa and an evaluation of their action].[原生动物产生的新型生物活性物质及其作用评估]
Izv Akad Nauk SSSR Biol. 1991 Nov-Dec(6):838-56.
4
[Experimental characteristics of the antileishmaniasis action of amphotericin B].[两性霉素B抗利什曼病作用的实验特征]
Antibiotiki. 1979 Apr;24(4):281-4.
5
The experimental chemotherapy of leishmaniasis, VI. The development of rodent models for cutaneous infection with L. major and L. mexicana amazonensis.利什曼病的实验性化疗,VI. 大型利什曼原虫和亚马逊利什曼原虫皮肤感染啮齿动物模型的建立。
Ann Trop Med Parasitol. 1980 Jun;74(3):299-319.
6
The effect of treatment of the associated disease on the development of amyloidosis in the experimental animal.相关疾病的治疗对实验动物淀粉样变性发展的影响。
J Pathol. 1983 Sep;141(1):11-5. doi: 10.1002/path.1711410103.
7
[Susceptibility to and the characteristics of the course of experimental leishmaniasis in different species of mammals infected with Leishmania major, L. turanica and L. gerbilli].[感染硕大利什曼原虫、图兰利什曼原虫和沙鼠利什曼原虫的不同种哺乳动物对实验性利什曼病的易感性及病程特征]
Med Parazitol (Mosk). 1991 Jan-Feb(1):35-9.
8
[Experimental visceral leishmaniasis in golden hamsters].[金黄仓鼠实验性内脏利什曼病]
Parazitologiia. 1987 Sep-Oct;21(5):637-42.
9
Experimental chemotherapy of leishmaniasis with adenosine analogue Formycin A, in combination with inhibitor of nucleoside transport, nitrobenzylthioinosinate.用腺苷类似物福米韦生联合核苷转运抑制剂硝基苄硫肌苷对利什曼病进行实验性化疗。
Drugs Exp Clin Res. 1992;18(10):423-6.
10
[The isoenzyme identification and pathogenic characteristics of the Leishmania isolated in natural foci of cutaneous leishmaniasis in the USSR].[苏联皮肤利什曼病自然疫源地分离出的利什曼原虫同工酶鉴定及致病特征]
Med Parazitol (Mosk). 1990 Sep-Oct(5):43-8.